We are live on
!
Find out more
FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$434M
1-Year Est. Return
9.09%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$766M
AUM Growth
+$94.4M
(+14%)
Cap. Flow
+$70.2M
Cap. Flow
% of AUM
9.16%
Top 10 Holdings %
Top 10 Hldgs %
34.82%
Holding
91
New
24
Increased
10
Reduced
32
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$30.4M |
| 2 |
Bunge Global
BG
|
+$28.2M |
| 3 |
Check Point Software Technologies
CHKP
|
+$21.5M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$17.4M |
| 5 |
Conagra Brands
CAG
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DWA
DREAMWORKS ANIMATION SKG INC CL-A
DWA
|
+$17.1M |
| 2 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$16.6M |
| 3 |
AT&T
T
|
+$12.2M |
| 4 |
PepsiCo
PEP
|
+$10.4M |
| 5 |
Archer Daniels Midland
ADM
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.26% |
| 2 | Technology | 16.11% |
| 3 | Financials | 13.68% |
| 4 | Energy | 12.49% |
| 5 | Consumer Staples | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
IBM
IBM
$216B
| $579K | 0.08% |
3,270
| – | – |
|
77
AbbVie
ABBV
$469B
| $562K | 0.07% |
12,570
| – | – |
|
78
RTX Corp
RTX
$294B
| $559K | 0.07% |
8,239
| – | – |
|
79
iShares Core S&P 500 ETF
IVV
$869B
| $524K | 0.07% |
3,100
| – | – |
|
80
Abbott
ABT
$187B
| $417K | 0.05% |
12,570
| – | – |
|
81
US Bancorp
USB
$98.6B
| $349K | 0.05% |
9,553
| – | – |
|
82
Wells Fargo
WFC
$256B
| $307K | 0.04% |
7,421
| – | – |
|
83
JPMorgan Chase
JPM
$925B
| $231K | 0.03% |
4,471
| – | – |
|
84
Pfizer
PFE
$143B
| $201K | 0.03% |
+7,371
| New | +$201K |
|
|
ACET
85
DELISTED
Aceto Corp
ACET
| $185K | 0.02% |
11,851
| – | – |
|
|
86
Archer Daniels Midland
ADM
$39.1B
| – | – |
-304,416
| Closed | -$10.3M |
|
87
Kroger
KR
$36.4B
| – | – |
-572,360
| Closed | -$9.88M |
|
|
88
PepsiCo
PEP
$195B
| – | – |
-126,717
| Closed | -$10.4M |
|
|
89
AT&T
T
$163B
| – | – |
-457,762
| Closed | -$12.2M |
|
|
MHFI
90
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| – | – |
-311,393
| Closed | -$16.6M |
|
|
WRES
91
DELISTED
WARREN RESOURCES INC
WRES
| – | – |
-16,000
| Closed | -$41K |
|
Similar funds
HCM
GS
IA
PAMS
SSWG
JWM
GDS
GPP
Foyston, Gordon, & Payne's Q3 2013 Portfolio in Review
As of Q3 2013, Foyston, Gordon, & Payne held 91 positions worth $766M, up 14% from $672M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Foyston, Gordon, & Payne deployed $70.2M of net new capital in Q3 2013, opening 24 new positions and adding to 10 existing holdings. Its largest new stake was Teva Pharmaceuticals: 780,584 shares worth $29.5M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was DREAMWORKS ANIMATION SKG INC CL-A, an estimated $17.1M trimmed.
- Foyston, Gordon, & Payne's largest Q3 2013 buy was Teva Pharmaceuticals: 780,584 shares worth $29.5M.
- Foyston, Gordon, & Payne added most to Conagra Brands in Q3 2013, an estimated $12M increase.
- Foyston, Gordon, & Payne's biggest Q3 2013 reduction was DREAMWORKS ANIMATION SKG INC CL-A, cutting an estimated $17.1M.
- Foyston, Gordon, & Payne fully exited MCGRAW-HILL FINANCIAL INC COM in Q3 2013, selling an estimated $16.6M.
- Foyston, Gordon, & Payne's ten largest holdings make up 35% of its $766M portfolio in Q3 2013.
- Foyston, Gordon, & Payne opened 24 new positions and closed 6 in Q3 2013.
- Foyston, Gordon, & Payne's portfolio value rose 14% quarter-over-quarter to $766M.
Based on Foyston, Gordon, & Payne's 13F filing for Q3 2013, filed 13 Nov 2013.